Literature DB >> 7451651

Hypoxia impairs vasodilation in the lung.

N F Voelkel, I F McMurtry, J T Reeves.   

Abstract

Alveolar hypoxia causes pulmonary vasoconstriction; we investigated whether hypoxia could also impair pulmonary vasodilation. We found in the isolated perfused rat lung a delay in vasodilation following agonist-induced vasoconstriction. The delay was not due to erythrocyte or plasma factors, or to alterations in base-line lung perfusion pressure. Pretreating lungs with arachidonic acid abolished hypoxic vasoconstriction, but did not influence the hypoxia-induced impairment of vasodilation after angiotensin II, bradykinin, or serotonin pressor responses. Progressive slowing of vasodilation followed angiotensin II-induced constriction as the lung oxygen tension fell progressively below 60 Torr. KCl, which is not metabolized by the lung, caused vasoconstriction; the subsequent vasodilation time was delayed during hypoxia. However, catecholamine depletion in the lungs abolished this hypoxic vasodilation delay after KCl-induced vasoconstriction. In lungs from high altitude rats, the hypoxia-induced vasodilation impairment after an angiotensin II pressor response was markedly less than it was in lungs from low altitude rats. We conclude from these studies that (a) hypoxia impairs vasodilation of rat lung vessels following constriction induced by angiotensin II, serotonin, bradykinin, or KCl, (b) hypoxia slows vasodilation following KCl-induced vasoconstriction probably by altering lung handling of norepinephrine, (c) the effect of hypoxia on vasodilation is not dependent on its constricting effect on lung vessels, (d) high altitude acclimation moderates the effect of acute hypoxia on vasodilation, and (e) the hypoxic impairment of vasodilation is possibly the result of an altered rate of dissociation of agonists from their membrane receptors on the vascular smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7451651      PMCID: PMC371593          DOI: 10.1172/JCI110019

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Pulmonary and extrapulmonary fate of angiotensin I.

Authors:  P Biron; L Campeau
Journal:  Rev Can Biol       Date:  1971-03

2.  The removal of noradrenaline in the pulmonary circulation of rat isolated lungs.

Authors:  V A Alabaster; Y S Bakhle
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

3.  Pulmonary fate of intravenous norepinephrine.

Authors:  J C Boileau; L Campeau; P Biron
Journal:  Rev Can Biol       Date:  1972-09

4.  Technique for measurement of norepinephrine and 5-hydroxytryptamine uptake by rabbit lung.

Authors:  C N Gillis; Y Iwasawa
Journal:  J Appl Physiol       Date:  1972-09       Impact factor: 3.531

5.  Uptake, metabolism and efflux of 14 C-5-hydroxytryptamine in isolated perfused rat lungs.

Authors:  A F Junod
Journal:  J Pharmacol Exp Ther       Date:  1972-11       Impact factor: 4.030

6.  Role of histamine in hypoxic pulmonary hypertension in the rat. II. Depletion of histamine, serotonin, and catecholamines.

Authors:  A Hauge; K L Melmon
Journal:  Circ Res       Date:  1968-03       Impact factor: 17.367

7.  Effect of hypoxia on the vascular response to isoproterenol and norepinephrine.

Authors:  T T Zsotér
Journal:  Am Heart J       Date:  1969-04       Impact factor: 4.749

8.  Angiotensinase with a high degree of specificity in plasma and red cells.

Authors:  P A KHAIRALLAH; F M BUMPUS; I H PAGE; R R SMEBY
Journal:  Science       Date:  1963-05-10       Impact factor: 47.728

9.  Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation.

Authors:  J Hughes; R H Roth
Journal:  Br J Pharmacol       Date:  1971-02       Impact factor: 8.739

10.  Calcium augments hypoxic vasoconstriction in lungs from high-altitude rats.

Authors:  N F Voelkel; K G Morris; I F McMurtry; J T Reeves
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1980-09
View more
  3 in total

1.  Effect of cyclic guanosine monophosphate on hypoxic and angiotensin-II-induced pulmonary vasoconstriction.

Authors:  K Fujimoto; A Sakai; S Yoshikawa; S Shinozaki; Y Matsuzawa; K Kubo; T Kobayashi; G Ueda; M Sekiguchi; N F Voelkel
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

3.  Cerium oxide nanoparticles protect rodent lungs from hypobaric hypoxia-induced oxidative stress and inflammation.

Authors:  Aditya Arya; Niroj Kumar Sethy; Sushil Kumar Singh; Mainak Das; Kalpana Bhargava
Journal:  Int J Nanomedicine       Date:  2013-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.